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The	 non-mammalian	 nonulosonic	 acid	 sugar	 pseudaminic	 acid	
(Pse)	 is	present	on	the	surface	of	a	number	of	human	pathogens	
including	Campylobacter	 jejuni	 and	Helicobacter	pylori	 and	other	
bacteria	such	as	multidrug	resistant	Acinetobacter	baumannii.	It	is	
likely	important	for	evasion	of	the	host	immune	sysyem,	and	also	






non-2-ulopyranosonic	 acid	 UDP-	 uridine	 diphosphate-,	 CMP-	
cytidine	monophosphate,	PEP	phosphoenol	pyruvate,	PLP	pyridoxal	
phosphate,	PMP	pyridoxamine	phosphate,	Ac-CoA	acetyl	coenzyme	
A,	 NAD(P)H	 nicotine	 adenine	 dinucleotide	 (phosphate),	 ˪-Glu	 ˪-
glutamate,	KDO	3-deoxy-ᴅ-manno-octulosonic	acid	
Introduction	
Nonulosonic	acids	 (NulOs)	are	nine-carbon	α-keto-acid	 sugars	 that	
are	 ubiquitous	 in	 Nature,	 occuring	 in	 several	 cell	 surface	
glycoconjugates	 where	 they	 play	 a	 crucial	 role	 in	 cell-cell	
interactions.	 Pseudaminic	 acids	 (Pse)	 are	 rare	 non-mammalian	
nonulosonic	 acids	 that	 belong	 to	 this	 class	 of	 sugars,	 and	 are	
epimeric	 at	 the	 C5,	 C7	 and	 C8	 positions	 when	 compared	 to	 the	
stereochemistry	 of	 the	 ubiquitous	 human	 sialic	 acid;	 neuraminic	
acid	 (Neu5Ac)	 1	 (Figure	 1).	 The	 general	 term	 pseudaminic	 acid	 is	
commonly	 used	 to	 describe	 the	 parent	 Pse5Ac7Ac	 structure	 2,	
which	differs	 in	 functionality	 from	Neu5Ac	by	 replacement	 	of	 the	
C7	 hydroxyl	 with	 an	 acetamido	 group	 and	 loss	 of	 a	 C9	 hydroxyl	
group	(Figure	1).	Pse5Ac7Ac	2	was	first	discovered	as	a	component	
of	 the	 Pseudonomas	 aeruginosa	 and	 Shigella	 Boydii	
lipopolysaccharides	 (LPS),	 with	 NMR	 used	 to	 assign	 the	















	 During	 the	 initial	 identification	 of	
Pse5Ac7Ac	2,	 a	derivative	was	also	 tentatively	 assigned	with	NMR	
peaks	 observed	 consistent	 with	 an	 N-(3-hydroxybutyryl)	 group	 at	
the	 C5	 position	 (Pse5Hb7Ac).
6
	 Subsequent	 research	 on	 other	 Pse	
structures	 has	 highlighted	 that	 derivatisation	 of	 the	 C5	 and	 C7	
acetamido	 groups	 is	 common	 (Figure	 2).
7
	 For	 example,	 C.	 jejuni	





Pse5Ac7Ac	 2	 and	 derivatives	 are	 most	 commonly	 found	 on	
bacterial	 cell	 surfaces	 with	 reports	 of	 LPS	 and	 capsular	
polysaccharide	(CPS)	containing	Pse,	in	addition	to	Pse	glycosylated	
flagella	 and	 pili.	 Unusually	 for	 a	 nulO,	 there	 is	 evidence	 for	
Pse5Ac7Ac	 2	 linked	 in	 both	 the	 α-	 and	 β-anomeric	 configuration.	
For	 example	P.	 aeruginosa	O13	 LPS	 incorporates	 a	 Pse5Ac7Ac(α2-
3)˪-FucAm	 bond	 3
8





rather	 than	 at	 the	 terminal	 position	 which	 is	 more	 typical	 of	
mamallian	human	sialic	acids,	and	can	act	as	a	glycosyl	acceptor	via	
its	 derivatives	 at	 the	 C5,	 or	 C7	 positions.	 Indeed	 the	 CPS	 of	
symbiont	 Sinorhizobium	 fredii	 is	 a	 Pse5Ac7Hb	 (C7	 N-(3-
hydroxybutyryl))	 homo-polysaccharide	 5	 with	 the	 α	 glycosidic	
linkage	between	the	anomeric	position	and	the	hydroxyl	group	on	
the	 C5	 N-hydroxybutyryl	 (Figure	 3).
10








	 This	 consistent	 positioning	 of	 Pse	 on	 bacterial	 cell	
surface	 structures	 such	 as	 flagella,	 pili,	 CPS	 and	 LPS,	 has	 been	
shown	 to	 provide	 a	 selective	 advantage	 to	 the	 bacteria	 and	 can	
have	 a	 direct	 role	 as	 a	 virulence	 factor.
7
	 For	 example,	 C.	 jejuni	
flagellin	 proteins	 (such	 as	 FlaA1)	 were	 shown	 to	 be	 glycosylated	











	 Similarly	H.	pylori	 FlaA	and	FlaB	 flagellin	
proteins	 have	 been	 found	 to	 be	 exclusively	 glycosylated	 with	
Pse5Ac7Ac	2	and	prevention	of	flagellin	glycosylation	resulted	in	no	
detectable	 flagella	 and	 non-motile	 bacterium.
3
	 As	 motility	 has	
previously	been	shown	to	be	a	key	factor	in	the	ability	of	these	two	
bacteria	 to	 establish	 an	 infection,
15,	 16
	 it	 is	 clear	 that	 therapeutics	
targeting	 the	Pse5Ac7Ac	2	biosynthesis	could	reduce	the	virulence	
of	such	bacteria.	Furthermore	it	has	been	proposed	that	Pse5Ac7Ac	
2	may	play	a	 role	 in	bacterial	 evasion	of	 the	host	 immune	 system	
due	 to	 its	 structural	 similarities	 to	 the	 human	 sugar	 Neu5Ac	 1.	
Indeed,	 many	 pathogens	 manipulate	 host	 immune	 system	 by	











A	 detailed	 understanding	 of	 the	 biosynthesis	 of	 this	 bacterial	
sugar	is	therefore	essential	as	inhibition	of	this	pathway	could	form	
the	 basis	 of	 a	 novel	 antimicrobial	 strategy.	 Herein	 we	 provide	 an	






Commonly	 nulOs	 are	 biosynthesised	 from	 the	 activated	 sugar	
uridine	 diphosphate-N-acetyl-α-ᴅ-glucosamine	 (UDP-GlcNAc)	 7,
19
	
before	 conversion	 to	 their	 activated	 glycosyl	 donor	 analogues	 by	
enzyme	 catalysed	 transfer	 of	 a	 cytidine	 monophosphate	 (CMP)	
group.	 In	 bacteria,	 biosynthesis	 of	 Neu5Ac	 1	 from	 UDP-GlcNAc	 7	
requires	only	two	enzymes;	a	UDP-GlcNAc	2-epimerase	to	hydrolyse	
the	UDP-	 group	 and	 epimerise	 the	 stereochemistry	 at	 C2,
20
	 and	 a	
Neu5Ac	 synthase	 that	 catalyses	 the	 condensation	 reaction	 of	
ManNAc	 8	 and	 phospho-enol-pyruvate	 (PEP)	 to	 afford	 the	
nonulosonic	 acid	 backbone	 (Scheme	 1).
21
	 In	 mammals,	 the	 UDP-
GlcNAc	2-epimerase	is	bifunctional	and	after	conversion	to	ManNAc	






It	 was	 hypothesised	 that	 the	 Pse5Ac7Ac	 2	 biosynthetic	 pathway	





H.	pylori	 and	C.	 jejuni	 flagella	are	predominantly	glycosylated	with	
Pse5Ac7Ac	 2,	 and	 derivatives,	 therefore	 the	 flagellin	 glycosylation	
gene	clusters	in	these	bacteria	were	initially	inspected	for	potential	
Pse	biosynthesis	 genes.	 Schirm	et	 al.	 initially	 identified	 four	 genes	
(HP0326A,	HP0326B,	HP0840	 and	HP0178)	 in	H.	 pylori	 that	 were	
found	 to	be	essential	 for	 the	production	of	Pse5Ac7Ac	2.
3
	HP0840	
was	 identified	as	 the	 first	enzyme	 in	the	Pse5Ac7Ac	2	biosynthetic	
pathway	 and	 upon	 inactivation	 of	 this	 gene	 there	 was	 an	
accumulation	 of	 UDP-GlcNAc	 7	 providing	 evidence	 for	 this	 as	 the	
Pse5Ac7Ac	 2	 precursor.
23
	 Sequence	 homology	 studies	 enabled	




	 Thus	 it	 was	 proposed	 that	 the	 final	
stages	of	Pse5Ac7Ac	biosynthesis	did	indeed	mimic	that	of	Neu5Ac	
1	 and	 that	 other	 biosynthetic	 enzymes	 would	 be	 required	 to	
process	 UDP-GlcNAc	 7	 into	 the	 Pse5Ac7Ac	 synthase	 substrate	 11.		
Putative	 UDP-GlcNAc	 dehydratase	 and	 aminotransferase	 enzymes	
were	 purified	 and	 their	 reaction	 products	 analysed	 by	 NMR.	 H.	
pylori	 (HP0840/HP0366)	 and	C.	 jejuni	 (Cj1293/Cj1294)	products	12	
and	 13	 were	 assigned	 as	 the	 first	 two	 intermediates	 in	 the	




potential	 Pse5Ac7Ac	 2	 biosynthetic	 genes	 by	 comparing	 the	
genomes	of	other	bacteria	also	known	to	display	surface	Pse5Ac7Ac	
2.	 Sequence	 alignment	 of	 HP0327	 suggested	 the	 enzyme	was	 the	
acetyl-transferase	 required	 to	 afford	 the	 desired	 diacetamido	
product	 14.
25
	 HP0326B	 displayed	 sequence	 homology	 with	 a	
glycosyltransferase	 enzyme	 suggesting	 it	 may	 be	 required	 for	 the	
transfer	of	Pse	onto	other	sugars	or	proteins	rather	than	involved	in	
Pse5Ac7Ac	 2	 biosynthesis.	 However	 upon	 mutation	 of	 this	 gene	
there	 was	 an	 accumulation	 of	 Pse5Ac7Ac	 2	 biosynthetic	
intermediates	 (12,	 13	 and	 14)	 rather	 than	 the	 expected	 CMP-
Pse5Ac7Ac	 that	 would	 accumulate	 if	 the	 gene	 encoded	 for	 a	
glycosyltransferase	suggesting	 that	 it	may	actually	be	 the	 required	




led	 to	 confirmation	 of	 all	 of	 the	 biosynthetic	 intermediates	 in	 the	
pathway	 which	 are	 analogous	 in	 H.	 pylori	 and	 C.	 jejuni.	 The	 five	







caused	a	 reduction	 in	motility,	 through	 loss	of	 	 flagella,	and	also	a	
loss	 of	 LPS,	 suggesting	 this	 locus	 has	 a	 role	 in	 both	 flagellar	
assembly	 and	 LPS	 biosynthesis.
27
	 A	 cluster	 of	 genes	 in	 this	 locus	
displayed	homology	to	the	biosynthetic	genes	found	in	C.	jejuni	and	
H.	pylori	 and	 comparison	highlighted	 conserved	domains	 for	 FlmA	
with	 PseB,	 FlmB	 with	 PseC	 and	 NeuB	 with	 PseI.	 However	 in	 A.	





	 The	 A.	 cavaie	 enzymes	 have	 not	 been	 as	 rigorously	
investigated	 as	 the	 C.	 jejuni	 and	 H.	 pylori	 enzymes	 and	 full	
biochemical	 analysis	 of	 the	 route	 in	 this	 organism	 has	 yet	 to	 be	
carried	 out.	 Further	 deviations	 from	 the	 original	 Pse5Ac7Ac	 2	
biosynthetic	pathway	were	discovered	when	the	pathway	from	the	
gram	positive	bacteria	B.	thuringiensis	was	investigated.	An	operon	
was	 identified	 containing	 seven	 genes	 that	 were	 proposed	 to	








and	 PseI	 enzymes	 and	 two	 B.	 thuringiensis	 enzymes	 that	 were	
predicted	as	dehydratases.	LC-MS	and	NMR	characterisation	of	the	
product	of	each	enzymatic	reaction	showed	that	two	enzymes	were	
required	 to	 carry	 out	 the	 PseB	 function.	 The	 first	 enzyme	 (Pen)	
converts	UDP-GlcNAc	7	into	UDP-6-deoxy-ᴅ-GlcNAc-5,6-ene	15	and	
a	 second	 enzyme	 (Pal)	 acts	 as	 a	 C4	 oxidase	 and	 C5,6	 reductase	






to	 UDP-4-keto-6-deoxy-β-˪-IdoNAc	 12.	 The	 proposed	 reaction	
mechanism	 follows	 three	 sequential	 steps;	 oxidation	 of	 the	 C4	
hydroxyl,	 dehydration	 at	 C6	 to	 form	 the	 alkene,	 followed	 by	
reduction	 to	 the	 methyl.
28
	 Characterisation	 of	 this	 enzyme	 was	
initially	 ambiguous,	 with	 confusion	 over	 its	 catalytic	 activity,	 co-
factor	 requirement	 and	 products	 released.	 Although	 PseB	
(FlaA1/HP0840	 in	H.	 pylori	 Cj1293	 in	 C.	 jejuni)	 displays	 conserved	











a	 sub-group	 that	 exhibits	 4,6-dehydratase	 activity	 on	 nucleotide	
activated	 sugars	 to	 form	 deoxy-hexoses.
31
	 There	 was	 also	 initial	
uncertainty	regarding	the	observed	4-keto	product	with	reports	of	









	 observed	 as	 the	hydrated	 form	 in	
aqueous	 solution	 16.
32
	 Upon	 in	 vitro	 incubation	 of	 UDP-GlcNAc	 7	
with	 the	 five	 Pse5Ac7Ac	 2	 biosynthetic	 enzymes	 and	 the	 CMP-
Pse5Ac7Ac	 synthetase	 enzyme,	 there	 was	 a	 drastic	 reduction	 in	
PseB	 activity	 as	 CMP-Pse5Ac7Ac	 accumulated.
26
	 Therefore	 PseB	
inhibition	with	 CMP-Pse5Ac7Ac	was	 investigated	 and	 found	 to	 be	





as	 FlaA1	 in	 H.	 pylori	 and	 sequence	 similarities	 suggested	 a	
nucleotide	 activated	 sugar	 as	 the	 likely	 substrate	 and	 a	 nicotine	
adenine	 dinucleotide	 (phosphate)	 (NAD(P)H)	 co-factor	 binding	
site.
23
	 UDP-GlcNAc	 7	was	 initially	 proposed	 to	 be	 the	 substrate	 in	
activity	assays	and	was	later	confirmed	by	observation	of	binding	in	
crystal	 structure	 substrate	 complexes.	 “Apo”	 crystal	 structures	 of	
PseB	 revealed	 electron	 density	 concurrent	 with	 a	 bound	 NADPH	





have	 favourable	 interactions	with	 the	molecule	 including	multiple	
H-bonding	 residues	 (Figure	4).
28
	 The	crystal	 structure	 revealed	 the	
characteristic	 SDR	 (S/T)YK	 catalytic	 triad	 in	 close	 proximity	 to	 the	
GlcNAc	moiety	as	well	as	an	aspartate	and	lysine.	The	combination	








hydroxyl	 producing	 the	 ketone	 intermediate	 17	 and	 reduced	 co-
factor.	 This	 step	 is	 followed	 by	 Lys133	 and	 Asp132	 catalysed	
dehydration	 across	 the	 C5	 (deprotonation)	 and	 C6	 bonds	
(dehydration)	 forming	 the	4-keto-5,6-ene	derivative	18.	Finally	 the	
reduced	 NADPH	 co-factor	 delivers	 a	 hydride	 to	 C6	 and	
simultaneously	a	stabilised	water	molecule	donates	a	proton	to	C5	






structures	 and	 biosynthesis	 often	 requires	 an	 aminotransferase	










H.	pylori	PseC	exists	as	a	homodimer	 in	solution	and	 in	 the	crystal	
structure	with	both	subunits	contributing	to	each	active	site	which	
is	located	near	the	dimer	interface	(Figure	5).		Crystal	structures	of	
H.	 pylori	 PseC	 additionally	 revealed	 the	 characteristic	 Type	 1	
aminotransferase	 PLP-binding	 site	 adjacent	 to	 the	 active	 site.
36
	 In	
particular	 the	 highly	 conserved	 aspartic	 acid	 and	 phenylalanine	
residue	 were	 identified	 as	 Asp154	 and	 Phe84	 respectively	 in	 H.	
pylori	 PseC	 (Figure	 6.a).	 Asp154	 is	 orientated	 to	 interact	with	 the	
pyridinium	nitrogen,	enhancing	 the	electron	sink	nature	of	 the	co-
factor,	 and	 the	 Phe84	 ring	 is	 orientated	 to	 π-stack	 with	 the	 co-
factor	pyridine	ring,	stabilising	binding	of	the	co-factor	(Figure	6.a).	
Crystal	structures	of	H.	pylori	PseC	in	complex	with	PLP	showed	it	to	
form	 an	 internal	 aldimine	 with	 the	 Lys183	 residue	 providing	
evidence	for	one	of	the	 intermediates	 in	the	proposed	mechanism	
of	 the	 first	 half	 transamination	 reaction	 (Figure	 6.b).
35
	 The	
identification	 of	 the	 natural	 amino	 donor	 of	 PLP-dependent	
aminotransferases	 has	 often	 been	 ambiguous.	 However	
spectroscopic	analysis	of	such	enzymes	consistently	show	turnover	
is	 achieved	 with	 ˪-glutamate	 (˪-Glu)	 as	 the	 free	 amino	 donor	 and	




of	 all	 twenty	 amino	 acids	 as	 the	 amino	 donor	 revealed	 that	




Co-crystallisation	 of	 H.	 pylori	 PseC,	 PLP	 and	 the	 proposed	
product	 UDP-4-amino-4,6-dideoxy-β-˪-AltNAc	 13	 also	 provided	
insight	 into	 the	 second	 half-transamination	 reaction	 as	 complexes	
formed	 showing	 the	 enzyme	 acting	 in	 reverse.	 Electron	 density	 in	
the	 active	 site	 could	 be	 attributed	 to	 a	 pyridoxamine	 phosphate	
(PMP)-sugar	aldimine	19	suggesting	that	direct	aminotransfer	from	
the	 PMP	 20	 to	 the	 keto-sugar	 12	 occurs	 and	 confirming	 the	
proximity	of	the	co-factor	binding	site	and	active	sites	(Figure	7.a).	
After	 consideration	 of	 the	 orientation	 of	 the	 active	 site	 residues,	
Lys183	was	 also	 suggested	 as	 the	 catalytic	 residue	 for	 the	 second	
half-reaction	 (Figure	 7.b).
35
	 The	 importance	 of	 this	 residue	 was	














product	 release	 (Scheme	 4).	 During	 the	 first	 half	 transamination,	
initially	an	enzyme-PLP	Schiff	base	 forms	 then	a	 free	amino	donor	
releases	the	enzyme	from	the	internal	aldimine	forming	an	external	




	 The	 second	 amino	 transfer	 occurs	 via	 attack	 of	 the	
PMP	 amine	 to	 the	 sugar	 C4	 keto	 producing	water	 and	 a	 ketimine	
intermediate	21	(Scheme	4).	Lys183	then	acts	as	a	base	to	abstract	
a	 	 labile	 proton	 (made	 so	 by	 the	 electron	 sink	 nature	 of	 the	 PMP	
pyridine	ring)	from	the	ketimine	structure	resulting	in	formation	of	
a	quinoid	intermediate	22.	Re-protonation	at	the	sugar	C4	position	






Although	 a	 structure	 for	 C.	 jejuni	 PseC	 has	 not	 been	 solved,	
detailed	 biochemical	 characterisation	 has	 been	 performed	 on	 this	
enzyme	and	similarities	with	the	H.	pylori	sequence	infers	a	similar	
fold.	 Sequence	 alignment	 reveals	 a	 43%	 identity	 between	 these	
enzymes	 and	 importantly,	 residues	 proximal	 to	 the	 co-factor	 and	
active	site	are	almost	always	identical	when	comparing	the	C.	jejuni	
PseC	 sequence	with	 the	H.	pylori	PseC	 sequence.	 For	example	 the	
H.	 pylori	 catalytic	 residue	 Lys183	 is	 aligned	 with	 the	 predicted	 C.	
jejuni	catalytic	residue;	Lys181	surrounded	by	homologous	residues.	
NMR	of	the	purified	product	from	coupled	C.	 jejuni	PseB	and	PseC	
reactions	 confirmed	 the	 identity	 of	 the	 product	 as	 UDP-4-amino-
4,6-dideoxy-β-˪-AltNAc	 13	 and	 suggested	 its	 role	 as	 the	 second	
enzyme	 in	 the	 Pse5Ac7Ac	 2	 biosynthetic	 pathway.
24
	 Coupled	
reactions	 also	 revealed	 that	 aminotransferase	 activity	 occurred	
without	the	addition	of	exogenous	PLP,	suggesting	that	similarly	to	
PseB,	 there	 is	 tight	 binding	 of	 the	 co-factor	 throughout	
purification.
38,	 40
	 However	 in	 some	 cases	 it	 was	 found	 that	
introduction	of	PLP	into	the	reaction	mixture	could	increase	activity	





The	 third	 step	 in	 the	 Pse5Ac7Ac	 2	 biosynthetic	 pathway	 is	 the	
transfer	 of	 an	 acetyl	 group	 to	C4	of	UDP-4-amino-4,6-dideoxy-β-˪-
AltNAc	13.
41
	 This	 step	 is	 catalysed	 by	 PseH,	 an	 aminoglycoside	N-
acetyltransferase	 from	 the	 GCN5-related	 N-acetyltransferase	
(GNAT)	 superfamily,	 and	 as	 such,	 utilises	 acetyl	 coenzyme	 A	 (Ac-
CoA)	 24	 as	 a	 co-factor.
42





of	 the	 core	 fold	 in	 all	 structures	 to	 date.
44
	 Structural	
characterisation	 of	 over	 twenty	 GNAT	 enzymes	 has	 revealed	










Å	 for	 134	 Cα	 atoms)	 with	 the	 major	 difference	 being	 the	 extra	 α	
helix	observed	in	H.	pylori	PseH		(Figure	8).	Both	of	the	PseH	crystal	
structures	 were	 identified	 as	 displaying	 structural	 similarities	 to	
WecD,
45,	 46
	 another	 acetyl-transferase	 with	 a	 nucleotide-linked	
sugar	 substrate.
47
	 However	 the	 GNAT	 family	 member	 with	 the	
highest	 structural	 similarity	 to	 C.	 jejuni	 PseH,	 Vibrio	 cholerae	
spermidine	 acetyltransferase,	 utilises	 a	 structurally	 unrelated	
substrate.
45













in	 the	 proximal	 α3,	 α4,	 β4	 and	 β5	 secondary	 structures	 (Figure	
9.a).
45
	 The	 co-factor	 in	 H.	 pylori	 PseH	 is	 held	 slightly	 differently	





this	 family	 of	 acetyltransferase	 enzymes	 catalyse	 the	 direct	 acetyl	
transfer	 from	 Ac-CoA	 24	 to	 substrates,
49-54
	 however	 there	 is	 an	
exception	 with	 evidence	 suggesting	 a	 yeast	 histone	
acetyltransferase	 progresses	 via	 an	 acetylated	 enzyme	
intermediate.
55
	 	 The	 crystal	 structures	 of	 the	 two	 PseH	 enzymes	
suggest	 that	 they	 follow	 the	 common	 direct	 acetyl	 transfer	




into	 the	 H.	 pylori	 PseH	 crystal	 structure.
45
	 A	 well-ordered	 water	
molecule	was	identified	with	hydrogen	bonds	to	acidic	residues	and	
it	 was	 suggested	 that	 this	 molecule	 could	 mediate	 the	
deprotonation	 of	 substrate	 13	 to	 promote	 nucleophilic	 attack	 on	
the	 co-factor	 carbonyl	 24	 forming	 the	 tetrahedral	 intermediate	
25.
46
	 A	 conserved	 tyrosine	 was	 identified	 in	 both	 PseH	 enzymes	
(Tyr128	 in	 C.	 jejuni	 PseH	 and	 Tyr138	 in	 H.	 pylori	 PseH)	 as	 the	







with	 conserved	 sequences	 of	 some	 UDP-sugar	 transferases.
3
	 PSI-




sequence	 displays	 only	 modest	 overall	 identity	 with	 this	 class	 of	
protein.	 Therefore	 it	was	 postulated	 that	 these	 enzymes	 could	 be	
the	 glycosyl	 hydrolase	 required	 to	 catalyse	 the	 “transfer”	 of	 the	




vitro	 biochemical	 analysis	 of	 the	 Cj1312	 enzyme	 confirmed	 it	 to	
catalyse	hydrolysis	of	UDP-	from	UDP-4-acetamido-4,6-dideoxy-β-˪-
AltNAc	 14	 when	 no	 activity	 was	 observed	 with	 either	 the	









also	 found	 to	 efficiently	 catalyse	 UDP-hydrolysis	 of	 UDP-4-
acetamido-4,6-dideoxy-β-˪-AltNAc	 14.
26
	 Calculation	 of	 the	 kinetic	
constants	 using	 a	 coupled	 assay	 for	 monitoring	 UDP-	 release	
confirmed	 that	 this	 was	 the	 biologicallly	 relevant	 role	 of	 PseG	 as	








	Mutations	 to	Cj1312	 resulted	 in	non-motile	
C.	 jejuni	 phenotypes	 lacking	 in	 flagella	 filaments	 and	 hook	
structures	 suggesting	 this	 enzyme	 to	 be	 essential	 for	 the	 correct	
assembly	 of	 flagella.
25
	 PseG	 candidates	 have	 been	 identified	 in	 a	
number	of	Pse	biosynthesis	gene	clusters	in	other	bacteria	and	have	
been	 found	 to	 only	 have	 weak	 sequence	 similarity,	 however	 a	




Glycosyl	 hydrolases	 have	 been	 shown	 to	 catalyse	 UDP-	
hydrolysis	 via	 attack	 of	 a	 water	 molecule	 onto	 the	 anomeric	
carbon
59,	 60
	 or	 onto	 one	 of	 the	 phosphorus	 atoms	 in	 the	 UDP-	
group.
61,	 62
	 	 The	 second	 mechanism	 was	 discounted	 for	 PseG	
following	 an	 experiment	 utilising	 H2
18
O,	 whereby	 mass	
spectrometry	 only	 identifed	 incorporation	 of	 the	 solvent	
18
O	 into	
the	 hydrolysed	 sugar	 and	 not	 the	 released	 nucleotide	 moiety.
57
	




catalysed	 reactions	 in	 the	 presence	 of	 D2O.	 	 It	was	 demonstrated	
that	 hydrolysis	 of	 UDP-4-acetamido-4,6-dideoxy-β-˪-AltNAc	 14	
occurs	 with	 an	 inversion	 of	 stereochemistry	 at	 C1	 to	 afford	 4-




	 This	 experiment	 also	 provided	 evidence	
against	the	mechanism	proceeding	through	a	glycal	intermediate	as	




The	 overall	 crystal	 structure	 of	 C.	 jejuni	 PseG	 (PDB	 3HBN)
58
		
showed	 high	 homology	 to	 that	 of	 an	 E.	 coli	 UDP-GlcNAc	
glycosyltransferase	 MurG	 (PDB	 1NLM),
63







	 The	 same	 reduction	 in	 turnover	 is	 observed	 upon	
mutation	 of	 the	 structurally	 conserved	 PseG	 His17	 to	 Phe	 or	 Leu	
suggesting	 that	 the	 enzymes	 share	 a	 mechanism;	 a	 catalytic	 His	




crystal	 structure	 elucidated	 a	 well-ordered	 active	 site	 water,	 that	
appears	anchored	via	hydrogen	bonds	to	His17	and	the	main	chain	
carbonyl	 of	 Ile13,	 as	 the	 proposed	 nucleophile	 for	 hydrolysis	
(Scheme	 6).	 Docking	 the	 substrate	 into	 the	 active	 site	 in	 three	
energetically	 favorable	 free-substrate	 conformations	 led	 to	






be	 identified	as	being	 involved	 in	 the	biosynthesis	of	Pse5Ac7Ac	2	
as	 it	mimics	 the	 final	biosynthetic	 step	 for	 the	production	of	 sialic	
acids	 and	 hence	 displays	 homology	 to	 well-characterised	 Neu5Ac	
synthase	 sequences.
3
	 	 Genes	 displaying	 homology	 to	 Neu5Ac	
synthases	were	 identified	 in	C.	 jejuni	 and	NeuB3	was	proposed	 as		
the	 most	 likely	 to	 be	 a	 Pse	 synthase	 as	 mutations	 to	 this	 gene	
prevented	 the	 correct	 formation	 of	 flagella.
65
	 In	 vitro	 assays	
confirmed	 that	 the	 C.	 jejuni	 NeuB3	 enzyme	 displayed	 activity	 for	









Enzyme	 catalysed	 condensation	 reactions	with	 PEP	 have	 been	
cited	 to	 proceed	 along	 one	 of	 two	 mechanistic	 pathways,	 for	




	 or	 as	 in	 other	nulO	 synthases	 such	 as	 in	
the	 biosynthesis	 of	 3-deoxy-ᴅ-manno-octulosonic	 acid	 (KDO),	 PseI	












results	 showed	 that	 the	 labelled	 oxygen	 remained	 bound	 to	 the	
released	 inorganic	 phosphate	 suggesting	 that	 PseI	 follows	 that	 of	
the	 KDO	 synthase.
66
	 Specifically,	 	 the	 ring	 open	 form	 of	 the	
substrate	27	is	activated	by	a	metal	ion	to	aid	nucleophilic	attack	of	
the	 PEP	 C3	 to	 generate	 an	 oxocarbenium	 ion	 28.	 A	 free	 hydroxyl	
then	 readily	 attacks	 the	 carbonyl	 to	 afford	 the	 tetrahedral	
intermediate	 29	 which	 releases	 an	 inorganic	 phopshate,	 thus	





In	 this	 review	 we	 have	 detailed	 the	 mechanistic	 and	 structural	
investigations	 into	 the	 enzymes	 integral	 for	 the	 biosynthesis	 of	
Pse5Ac7Ac	2	in	bacteria,	including	pathogens	C.	jejuni	and	H.	pylori.	
Using	 insights	 gleamed	 from	 enzymology	 studies	 these	 well	
characterised	 enzymes	 have	 previously	 been	 screened	 with	 small	
molecules	 for	 inhibition,	 with	 three	 validated	 PseB	 inhibitors	
displaying	 inhibition	 activity	 in	 cell-based	 assays.
72
	 It	 is	 our	 hope	


































































































































































































































































Scheme	2.	Pse5Ac7Ac	 2	biosynthesis;	detailing	 the	 intermediates	 identified	 in	C.	
jejuni	and	H.	pylori	(blue)	and	enzymatic	deviations	occurring	in	A.	caviae	(red)	and	
B.	thuringiensis	(green)	highlighted.		
























































































Figure	 8	Overlay	 of	 the	 C.	 jejuni	 (PDB	 4XPL)	 and	 H.	 pylori	 (PDB	 4RI1)	 PseH	 crystal	
structures,	highlighting	the	conservation	of	secondary	structure	features	and	the	single



























Scheme	 5	 Acetyltransfer	 mechanism	 for	 synthesis	 of	 UDP-4-acetamido-4,6-
dideoxy-β-ɩ-AltNAc	 14	 showing	 the	 proposed	 water	 mediated	 amine	
deprotonation	 to	 afford	 nucleophilic	 attack	 on	 acetyl-CoA	 24.	 An	 active	 site	
tyrosine	 is	 also	 depicted	as	 it	 has	 been	proposed	as	 the	 catalytic	 acid	utilised	 to	
stabilise	intermediates	and	the	anionic	CoA	byproduct	26.	
Scheme	6	The	proposed	mechanism	for	PseG;	His17	is	predicted	to	behave	as	a	
catalytic	base,	deprotonating	a	water	molecule	anchored	by	the	Ile13	backbone	
carbonyl	to	generate	a	hydroxide	nucleophile.	The	hydroxide	attacks	the	anomeric	
carbon	of	the	substrate	14	hydrolysing	the	UDP	group	to	generate	the	product	11	
with	inversion	of	stereochemistry	(molecular	modelling	of	the	substrate	into	the	
crystal	structures	suggest	it	binds	in	a	twist-boat	conformation	however	this	has	
been	omitted	for	simplicity	of	the	scheme).	
Figure	10	Overlay	of	ligand	bound	crystal	structures	with	the	putative	catalytic	
histidine	residues	highlighted	(PseG	His17	blue,	MurG	His19	red)	proximal	to	the	
ligand	binding	site.	PseG	(pink)	with	bound	UDP	(magenta,	PDB	3HBN)	and	MurG	(ice	
blue)	with	bound	UDP-GlcNAc	(cyan,	PDB	1NLM).	
	
	
	
	
	
	
	
	
	
	
	
	
Scheme	7	C.	jejuni	PseI	pseudaminic	acid	synthetase	PEP	condensation	mechanism;	PEP	undergoes	nucleophilic	attack	on	the	open	form	of	the	substrate	27	to	afford	an	
oxocarbenium	28	.	Attack	by	a	hydroxyl	generates	the	tetrahedral	intermediate	29	which	releases	an	inorganic	phosphate	to	afford	the	desired	nonulosonic	acid	30	that	ring	
closes	as	the	desired	Pse5Ac7Ac	2.	
